{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:21:41Z","timestamp":1793784101995,"version":"4.6.1"},"reference-count":250,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008413","name":"University of Dayton","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"The Francis Crick Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"University of Strasbourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Government of Catalonia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001673","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xpro.2026.104717","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:09:18Z","timestamp":1784938158000},"page":"104717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Researcher\u2019s guide to rodent models of Down syndrome: Recent insights and translational perspectives"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9897-7372","authenticated-orcid":false,"given":"Mir A.","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4094-1852","authenticated-orcid":false,"given":"Andrew","family":"Folz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2518-3902","authenticated-orcid":false,"given":"Daniella B.","family":"Victorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9799-7246","authenticated-orcid":false,"given":"Xu-Qiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-6886","authenticated-orcid":false,"given":"Xinxin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah K.","family":"Borden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2462-7150","authenticated-orcid":false,"given":"Marie-Claude","family":"Potier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0853-6865","authenticated-orcid":false,"given":"Mara","family":"Dierssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Hiratsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kazuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6624-4719","authenticated-orcid":false,"given":"Kristy","family":"Welshhans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5775-5162","authenticated-orcid":false,"given":"Michelle","family":"Maugham-Macan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-2086","authenticated-orcid":false,"given":"Antonella","family":"Tramutola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8474-1487","authenticated-orcid":false,"given":"Eitan","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3581-0850","authenticated-orcid":false,"given":"Roger","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-5037","authenticated-orcid":false,"given":"Randall J.","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Eugene","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-6900","authenticated-orcid":false,"given":"Yann","family":"H\u00e9rault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2439-0798","authenticated-orcid":false,"given":"Victor L.J.","family":"Tybulewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2850-9936","authenticated-orcid":false,"given":"Elizabeth M.C.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9226-7831","authenticated-orcid":false,"given":"Aaron","family":"Sathyanesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2026.104717_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xpro.2026.104717_bib2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down Syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.pbr.2019.09.001","article-title":"Influence of allelic differences in Down syndrome","volume":"251","author":"Roper","year":"2020","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.xpro.2026.104717_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1198129","article-title":"From neurodevelopment to neurodegeneration: utilizing human stem cell models to gain insight into Down syndrome","volume":"14","author":"Watson","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.1050432","article-title":"Alzheimer\u2019s disease like neuropathology in Down syndrome cortical organoids","volume":"16","author":"Zhao","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib6","doi-asserted-by":"crossref","DOI":"10.1042\/NS20210054","article-title":"Cell models for Down syndrome-Alzheimer\u2019s disease research","volume":"6","author":"Wu","year":"2022","journal-title":"Neuronal Signaling"},{"key":"10.1016\/j.xpro.2026.104717_bib7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.stem.2019.04.014","article-title":"OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xpro.2026.104717_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41591-026-04211-1","article-title":"Single-cell atlas of the developing Down syndrome brain cortex","volume":"32","author":"Lattke","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib9","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1038\/s41467-025-63752-0","article-title":"Molecular cartography of the human down syndrome and trisomic mouse brain","volume":"16","author":"Feng","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2026.104717_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj0385","article-title":"A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction","volume":"10","author":"Bansal","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xpro.2026.104717_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41380-023-02333-3","article-title":"Cerebral organoids with chromosome 21 trisomy secrete Alzheimer\u2019s disease-related soluble aggregates detectable by single-molecule-fluorescence and super-resolution microscopy","volume":"29","author":"Fertan","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.xpro.2026.104717_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.stem.2020.02.011","article-title":"Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery","volume":"26","author":"Sharma","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xpro.2026.104717_bib13","series-title":"Translational Neuroscience: Toward New Therapies","article-title":"From Rodent Behavioral Models to Human Disorders","author":"Robbins","year":"2015"},{"key":"10.1016\/j.xpro.2026.104717_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tig.2020.09.017","article-title":"All Creatures Great and Small: New Approaches for Understanding Down Syndrome Genetics","volume":"37","author":"Moyer","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl8189","article-title":"A genomic timescale for placental mammal evolution","volume":"380","author":"Foley","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.xpro.2026.104717_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.941855","article-title":"Neurodevelopment in Down syndrome: Concordance in humans and models","volume":"16","author":"Klein","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.909669","article-title":"Rodent Modeling of Alzheimer\u2019s Disease in Down Syndrome: In vivo and ex vivo Approaches","volume":"16","author":"Farrell","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib18","article-title":"Ts66Yah, a mouse model of Down syndrome with improved construct and face validity","volume":"15","author":"Duchon","year":"2022","journal-title":"Model Mech"},{"key":"10.1016\/j.xpro.2026.104717_bib19","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1126\/science.1114535","article-title":"An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes","volume":"309","author":"O\u2019Doherty","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.xpro.2026.104717_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56223","article-title":"A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21","volume":"9","author":"Kazuki","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.xpro.2026.104717_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1098992","article-title":"A chromosome 21 critical region does not cause specific Down syndrome phenotypes","volume":"306","author":"Olson","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.xpro.2026.104717_bib22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00439-011-0980-2","article-title":"Genetic analysis of Down syndrome-associated heart defects in mice","volume":"130","author":"Liu","year":"2011","journal-title":"Hum. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib23","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","article-title":"A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions","volume":"19","author":"Yu","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib251","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00439-013-1407-z","article-title":"Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice","volume":"133","author":"Liu","year":"2014","journal-title":"Hum. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11614","article-title":"Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel","volume":"5","author":"Lana-Elola","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.xpro.2026.104717_bib25","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/ddad056","article-title":"Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosome","volume":"32","author":"Xing","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajhg.2021.12.015","article-title":"A transchromosomic rat model with human chromosome 21 shows robust Down syndrome features","volume":"109","author":"Kazuki","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib27","series-title":"Genetic Models of Down Syndrome","first-page":"1","article-title":"Mouse Models of Down Syndrome","author":"Folz","year":"2025"},{"key":"10.1016\/j.xpro.2026.104717_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00335-016-9661-8","article-title":"Mouse models of Down syndrome: gene content and consequences","volume":"27","author":"Gupta","year":"2016","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.xpro.2026.104717_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behaviour deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","article-title":"Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn","volume":"22","author":"Reinholdt","year":"2011","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.xpro.2026.104717_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2010.10.023","article-title":"The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome","volume":"217","author":"Duchon","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.xpro.2026.104717_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2010.09.107","article-title":"Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice","volume":"1366","author":"Yu","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.xpro.2026.104717_bib33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/dmm.029728","article-title":"Rodent models in Down syndrome research: impact and future opportunities","volume":"10","author":"Herault","year":"2017","journal-title":"Model Mech"},{"key":"10.1016\/j.xpro.2026.104717_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108379","article-title":"Neocortical neuronal production and maturation defects in the TcMAC21 mouse model of Down syndrome","volume":"26","author":"Kurabayashi","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.xpro.2026.104717_bib35","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0040-25.2025","article-title":"Disrupted Neurogenesis from Basal Intermediate Precursor Cells Alters the Postnatal Neocortex in the TcMAC21 Mouse Model of Down Syndrome","volume":"45","author":"Atak","year":"2025","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2025.107686","article-title":"Altered synaptic functions in a humanized mouse model of down syndrome (TcMAC21): Implications for seizure susceptibility","volume":"218","author":"Shao","year":"2025","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.xpro.2026.104717_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41398-025-03744-2","article-title":"Altered motor coordination, vocal communication, and cerebellar circuit connectivity in mice carrying a near-complete human chromosome 21","volume":"16","author":"Stander","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.xpro.2026.104717_bib38","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049712","article-title":"Overexpression screen of chromosome 21 genes reveals modulators of Sonic hedgehog signaling relevant to Down syndrome","volume":"16","author":"Moyer","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.xpro.2026.104717_bib39","article-title":"TcMAC21 mouse model recapitulates abnormal vascular physiology observed in humans with Down syndrome","volume":"13","author":"Zheng","year":"2025","journal-title":"Phys. Rep."},{"key":"10.1016\/j.xpro.2026.104717_bib40","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.2147\/NSS.S545188","article-title":"Sleep Fragmentation in TcMAC21 Mouse Model of Down Syndrome","volume":"17","author":"Tusk","year":"2025","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.xpro.2026.104717_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86023","article-title":"Hypermetabolism in mice carrying a near-complete human chromosome 21","volume":"12","author":"Sarver","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.xpro.2026.104717_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00670","article-title":"Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions","volume":"14","author":"Dierssen","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1242\/dmm.026120","article-title":"Rodent models in neuroscience research: is it a rat race? Dis","volume":"9","author":"Ellenbroek","year":"2016","journal-title":"Model. Mech."},{"key":"10.1016\/j.xpro.2026.104717_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102382","article-title":"Microcell-mediated chromosome transfer between non-identical human iPSCs","volume":"35","author":"Uno","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xpro.2026.104717_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50292","article-title":"Micronuclei-based model system reveals functional consequences of chromothripsis in human cells","volume":"8","author":"Kneissig","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.xpro.2026.104717_bib46","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1142210","article-title":"Effects of aneuploidy on cellular physiology and cell division in haploid yeast","volume":"317","author":"Torres","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.xpro.2026.104717_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.neo.2019.02.003","article-title":"Single Chromosome Aneuploidy Induces Genome-Wide Perturbation of Nuclear Organization and Gene Expression","volume":"21","author":"Braun","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.xpro.2026.104717_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.stem.2021.12.002","article-title":"Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors","volume":"29","author":"Meharena","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xpro.2026.104717_bib49","first-page":"196","article-title":"Unraveling the enigma of mental disorders: a genetics-first approach and the role of mouse models based on rare disease-susceptible genome variants","volume":"87","author":"Kondo","year":"2025","journal-title":"Nagoya J. Med. Sci."},{"key":"10.1016\/j.xpro.2026.104717_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq1818","article-title":"Mouse models of neurodegeneration: Know your question, know your mouse","volume":"11","author":"Fisher","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib51","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1002\/cpmo.79","article-title":"Behavioral Phenotyping for Down Syndrome in Mice","volume":"10","author":"Roper","year":"2020","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.xpro.2026.104717_bib52","article-title":"Longitudinal neuroanatomical and behavioral analyses show phenotypic drift and variability in the Ts65Dn mouse model of Down syndrome","volume":"13","author":"Shaw","year":"2020","journal-title":"Model Mech"},{"key":"10.1016\/j.xpro.2026.104717_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060482","article-title":"Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome","volume":"8","author":"Gribble","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xpro.2026.104717_bib54","article-title":"Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1\/Yey mouse models of Down syndrome","volume":"11","author":"Aziz","year":"2018","journal-title":"Model Mech"},{"key":"10.1016\/j.xpro.2026.104717_bib55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biopsych.2023.02.012","article-title":"The Impact of Mmu17 Non-Hsa21 Orthologous Genes in the Ts65Dn Mouse Model of Down Syndrome: The Gold Standard Refuted","volume":"94","author":"Guedj","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.xpro.2026.104717_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-5380-1-9","article-title":"Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression","volume":"7","author":"Belzung","year":"2011","journal-title":"Biol. Mood Anxiety Disord."},{"key":"10.1016\/j.xpro.2026.104717_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/584071","article-title":"Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities","volume":"2012","author":"Rueda","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.xpro.2026.104717_bib58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/10738584241271414","article-title":"Neuronal oscillations in cognition: Down syndrome as a model of mouse to human translation","volume":"31","author":"Chang","year":"2025","journal-title":"Neuroscientist"},{"key":"10.1016\/j.xpro.2026.104717_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1225228","article-title":"Distinct neuroanatomical and neuropsychological features of Down syndrome compared to related neurodevelopmental disorders: a systematic review","volume":"17","author":"Hamadelseed","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005983","article-title":"Hedgehog Agonist Therapy Corrects Structural and Cognitive Deficits in a Down Syndrome Mouse Model","volume":"5","author":"Das","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib75","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/revneuro-2022-0067","article-title":"Brain circuit pathology in Down syndrome: from neurons to neural networks","volume":"34","author":"Bartesaghi","year":"2023","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00688755","article-title":"Spine distribution along the apical dendrites of the pyramidal neurons in Down\u2019s syndrome. A quantitative Golgi study","volume":"50","author":"Suetsugu","year":"1980","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xpro.2026.104717_bib61","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/BF00294247","article-title":"Down\u2019s dyndrome and Alzheimer\u2019s disease: dendritic spine counts in the hippocampus","volume":"79","author":"Ferrer","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xpro.2026.104717_bib62","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1212\/WNL.44.6.1039","article-title":"Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down\u2019s syndrome","volume":"44","author":"Kesslak","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.xpro.2026.104717_bib63","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.156.4.564","article-title":"MRI volumes of the hippocampus and amygdala in adults with Down\u2019s syndrome with and without dementia","volume":"156","author":"Aylward","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.xpro.2026.104717_bib64","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1212\/WNL.56.7.972","article-title":"Amygdala and hippocampal volumes in children with Down syndrome: a high-resolution MRI study","volume":"56","author":"Pinter","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.xpro.2026.104717_bib65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2004.06.075","article-title":"Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome","volume":"1022","author":"Kurt","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.xpro.2026.104717_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainres.2006.05.022","article-title":"Hippocampal hypocellularity in the Ts65Dn mouse originates early in development","volume":"1104","author":"Lorenzi","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.xpro.2026.104717_bib67","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/hipo.20308","article-title":"Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice","volume":"17","author":"Contestabile","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.xpro.2026.104717_bib68","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","article-title":"Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome","volume":"18","author":"Guidi","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.xpro.2026.104717_bib69","doi-asserted-by":"crossref","first-page":"fcab088","DOI":"10.1093\/braincomms\/fcab088","article-title":"High resolution structural and functional MRI of the hippocampus in young adults with Down syndrome","volume":"3","author":"Koenig","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.xpro.2026.104717_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/hmg\/9.2.195","article-title":"Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse","volume":"9","author":"Baxter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib71","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1176\/appi.ajp.158.10.1659","article-title":"Neuroanatomy of Down\u2019s syndrome: a high-resolution MRI study","volume":"158","author":"Pinter","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.xpro.2026.104717_bib73","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1523\/JNEUROSCI.2198-13.2013","article-title":"Size does not always matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal SAG treatment","volume":"33","author":"Gutierrez-Castellanos","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib74","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1750-3639.2010.00459.x","article-title":"Widespread Proliferation Impairment and Hypocellularity in the Cerebellum of Fetuses with Down Syndrome","volume":"21","author":"Guidi","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.xpro.2026.104717_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106073","article-title":"Cognitive impairments in a Down syndrome model with abnormal hippocampal and prefrontal dynamics and cytoarchitecture","volume":"26","author":"Muza","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.xpro.2026.104717_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2023.114323","article-title":"Ultrasonic vocalization phenotypes in the Ts65Dn and Dp(16)1Yey mouse models of Down syndrome","volume":"271","author":"Glass","year":"2023","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.xpro.2026.104717_bib78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroscience.2018.02.009","article-title":"Sleep Behavior and EEG Oscillations in Aged Dp(16)1Yey\/+ Mice: A Down Syndrome Model","volume":"376","author":"Levenga","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.xpro.2026.104717_bib79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-444-54299-1.00011-X","article-title":"A Sonic hedgehog (Shh) response deficit in trisomic cells may be a common denominator for multiple features of Down syndrome","volume":"197","author":"Currier","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.xpro.2026.104717_bib80","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.celrep.2019.12.065","article-title":"Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome","volume":"30","author":"Chang","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xpro.2026.104717_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1171797","article-title":"Glutamatergic synaptic deficits in the prefrontal cortex of the Ts65Dn mouse model for Down syndrome","volume":"17","author":"Thomazeau","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib82","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1523\/JNEUROSCI.1766-04.2004","article-title":"Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome","volume":"24","author":"Kleschevnikov","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.877711","article-title":"Developmental Neuropathology and Neurodegeneration of Down Syndrome: Current Knowledge in Humans","volume":"10","author":"Hasina","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xpro.2026.104717_bib84","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72904","article-title":"Charting brain growth and aging at high spatial precision","volume":"11","author":"Rutherford","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.xpro.2026.104717_bib85","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41583-019-0152-2","article-title":"Emerging connections between cerebellar development, behavior, and complex brain disorders","volume":"20","author":"Sathyanesan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib86","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1429-24.2025","article-title":"From Circuits to Lifespan: Translating Mouse and Human Timelines with Neuroimaging-Based Tractography","volume":"45","author":"Cottam","year":"2025","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2018.03.005","article-title":"Developmental excitatory-to-inhibitory GABA polarity switch is delayed in Ts65Dn mice, a genetic model of Down syndrome","volume":"115","author":"Lysenko","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib88","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1523\/JNEUROSCI.2513-15.2016","article-title":"Absence of Prenatal Forebrain Defects in the Dp(16)1Yey\/+ Mouse Model of Down Syndrome","volume":"36","author":"Goodliffe","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib89","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","article-title":"Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome","volume":"93","author":"Holtzman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xpro.2026.104717_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007383","article-title":"Analysis of motor dysfunction in Down Syndrome reveals motor neuron degeneration","volume":"14","author":"Watson-Scales","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib91","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnbeh.2015.00265","article-title":"Timing of therapies for Down syndrome: the sooner, the better","volume":"9","author":"Stagni","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib93","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N","article-title":"Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice","volume":"217","author":"Richtsmeier","year":"2000","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.xpro.2026.104717_bib94","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ajmg.10175","article-title":"Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome","volume":"107","author":"Richtsmeier","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib95","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mod.2008.11.002","article-title":"A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog","volume":"126","author":"Roper","year":"2009","journal-title":"Mech. Dev."},{"key":"10.1016\/j.xpro.2026.104717_bib96","first-page":"4856","article-title":"Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome","volume":"25","author":"McElyea","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011873","article-title":"Ripply3 overdosage induces mid-face shortening through Tbx1 downregulation in Down syndrome models","volume":"21","author":"Ahumada Saavedra","year":"2025","journal-title":"PLoS Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib98","doi-asserted-by":"crossref","DOI":"10.1242\/dev.201077","article-title":"Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes","volume":"150","author":"Redhead","year":"2023","journal-title":"Development"},{"key":"10.1016\/j.xpro.2026.104717_bib99","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bone.2010.09.028","article-title":"Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice","volume":"48","author":"Blazek","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.xpro.2026.104717_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042967","article-title":"Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment","volume":"7","author":"Fowler","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xpro.2026.104717_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117046","article-title":"Compromised femoral and lumbovertebral bone in the Dp(16)1Yey Down syndrome mouse model","volume":"181","author":"Lamantia","year":"2024","journal-title":"Bone"},{"key":"10.1016\/j.xpro.2026.104717_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116471","article-title":"Low bone mass and impaired fracture healing in mouse models of Trisomy21 (Down syndrome)","volume":"162","author":"Sherman","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.xpro.2026.104717_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117648","article-title":"Altered digit tip blastema differentiation and bone regeneration in skeletally mature Ts65Dn Down syndrome mice","volume":"201","author":"Wolff","year":"2025","journal-title":"Bone"},{"key":"10.1016\/j.xpro.2026.104717_bib104","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2559.2000.00872.x","article-title":"Histological assessment of vertebral bone in a Down\u2019s syndrome adult with osteoporosis","volume":"36","author":"Grimwood","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.xpro.2026.104717_bib105","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00198-017-4133-x","article-title":"Bone mineral density in adults with Down syndrome","volume":"28","author":"Carf\u00ec","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.xpro.2026.104717_bib106","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050914","article-title":"Sex-specific trisomic Dyrk1a-related skeletal phenotypes during development in a Down syndrome model","volume":"17","author":"LaCombe","year":"2024","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.xpro.2026.104717_bib107","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049927","article-title":"Genetic dissection of triplicated chromosome 21 orthologs yields varying skeletal traits in Down syndrome model mice","volume":"16","author":"Sloan","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.xpro.2026.104717_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115367","article-title":"Interaction of sexual dimorphism and gene dosage imbalance in skeletal deficits associated with Down syndrome","volume":"136","author":"Thomas","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.xpro.2026.104717_bib109","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3390\/ijms24032918","article-title":"Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation","volume":"24","author":"Mollo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xpro.2026.104717_bib110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/CIRCGENETICS.111.960872","article-title":"Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population","volume":"5","author":"Li","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1534\/genetics.116.188045","article-title":"Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier","volume":"203","author":"Li","year":"2016","journal-title":"Genetics"},{"key":"10.1016\/j.xpro.2026.104717_bib112","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add6883","article-title":"Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome","volume":"16","author":"Lana-Elola","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib113","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41586-025-09593-9","article-title":"Myocardial reprogramming by HMGN1 underlies heart defects in trisomy 21","volume":"647","author":"Ranade","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104717_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2025.113103","article-title":"Aberrant tissue mechanics and mechanotransduction during heart development in down syndrome","volume":"195","author":"Reeser","year":"2026","journal-title":"J. Biomech."},{"key":"10.1016\/j.xpro.2026.104717_bib115","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/genes14091819","article-title":"Lung and Heart Biology of the Dp16 Mouse Model of down Syndrome: Implications for Studying Cardiopulmonary Disease","volume":"14","author":"Colvin","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.xpro.2026.104717_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00263","article-title":"Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging","volume":"10","author":"Duval","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib117","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-018-0133-9","article-title":"Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome","volume":"7","author":"Tramutola","year":"2018","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.xpro.2026.104717_bib118","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/18715273113126660184","article-title":"The Akt-mTOR pathway in Down\u2019s syndrome: the potential use of rapamycin\/rapalogs for treating cognitive deficits","volume":"13","author":"Troca-Mar\u00edn","year":"2014","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.xpro.2026.104717_bib119","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xpro.2026.104717_bib120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41419-019-1752-5","article-title":"mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy","volume":"10","author":"Bordi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150713","article-title":"Brain insulin resistance in Down syndrome: Involvement of PI3K-Akt\/mTOR axis in early-onset of Alzheimer\u2019s disease and its potential as a therapeutic target","volume":"733","author":"Azimzadeh","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xpro.2026.104717_bib122","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13041-021-00795-6","article-title":"Prenatal treatment with rapamycin restores enhanced hippocampal mGluR-LTD and mushroom spine size in a Down\u2019s syndrome mouse model","volume":"14","author":"Urbano-G\u00e1mez","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.xpro.2026.104717_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101162","article-title":"Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome","volume":"23","author":"Di Domenico","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.xpro.2026.104717_bib124","first-page":"189","article-title":"Rapamycin treatment for Alzheimer\u2019s disease and related dementias: a pilot phase 1 clinical trial. Commun","volume":"5","author":"Gonzales","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.xpro.2026.104717_bib125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.freeradbiomed.2021.01.042","article-title":"Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome","volume":"165","author":"Lanzillotta","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104772","article-title":"Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome","volume":"137","author":"Tramutola","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib127","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/alz.12499","article-title":"Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles","volume":"18","author":"Perluigi","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.xpro.2026.104717_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12010111","article-title":"Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer\u2019s Disease-like Neuropathology in a Mouse Model for Down Syndrome","volume":"12","author":"Tramutola","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.xpro.2026.104717_bib129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40268-020-00296-2","article-title":"Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome","volume":"20","author":"Rosenbloom","year":"2020","journal-title":"Drugs R&D"},{"key":"10.1016\/j.xpro.2026.104717_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1310","article-title":"Single-cell landscape analysis reveals systematic senescence in mammalian Down syndrome","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.583801","article-title":"mTORC1 Transcriptional Regulation of Ribosome Subunits, Protein Synthesis, and Molecular Transport in Primary Human Trophoblast Cells","volume":"8","author":"Rosario","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xpro.2026.104717_bib132","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40478-025-02090-0","article-title":"Complement pathway dysregulation and astrocyte alterations in Down syndrome: evidence from postmortem brain tissue and iPSC-derived astrocytes","volume":"14","author":"Teles e Silva","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.xpro.2026.104717_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1137123","article-title":"Single-cell RNA sequencing of neural stem cells derived from human trisomic iPSCs reveals the abnormalities during neural differentiation of Down syndrome","volume":"16","author":"Qiu","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib134","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104717_bib135","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1038\/s41588-024-01961-x","article-title":"Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer\u2019s disease","volume":"56","author":"Miyoshi","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106491","article-title":"Spatial omics reveals molecular changes in focal cortical dysplasia type II","volume":"195","author":"Vermeulen","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib137","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12035-025-05432-0","article-title":"Proteome Signature of Alzheimer-Like Phenotypes in Frontal Cortices From Young and Old Individuals With Down Syndrome","volume":"63","author":"Di Domenico","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.xpro.2026.104717_bib138","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/ars.2016.6686","article-title":"Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology","volume":"26","author":"Tramutola","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.xpro.2026.104717_bib139","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neurobiolaging.2017.11.010","article-title":"Proteomic Analysis of Six- and Twelve-Month Hippocampus and Cerebellum in a Murine Down Syndrome Model","volume":"63","author":"Vacano","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.xpro.2026.104717_bib140","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-065402","article-title":"Developmental Milestones for Children With Down Syndrome","volume":"154","author":"Baumer","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.xpro.2026.104717_bib141","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ridd.2016.09.019","article-title":"Growing up with Down syndrome: Development from 6 months to 10.7 years","volume":"59","author":"Marchal","year":"2016","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.xpro.2026.104717_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021879","article-title":"Development, problem behavior, and quality of life in a population based sample of eight-year-old children with Down syndrome","volume":"6","author":"van Gameren-Oosterom","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xpro.2026.104717_bib143","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jpeds.2013.06.054","article-title":"Problem behavior of individuals with Down syndrome in a nationwide cohort assessed in late adolescence","volume":"163","author":"van Gameren-Oosterom","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.xpro.2026.104717_bib144","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3104\/reports.313","article-title":"Mental health, behaviour and intellectual abilities of people with Down syndrome","volume":"11","author":"M\u00e4\u00e4tt\u00e4","year":"2006","journal-title":"Downs. Syndr. Res. Pract."},{"key":"10.1016\/j.xpro.2026.104717_bib145","doi-asserted-by":"crossref","first-page":"H542","DOI":"10.1152\/ajpheart.00544.2022","article-title":"Sex differences in cardiovascular disease and dysregulation in Down syndrome","volume":"324","author":"Bates","year":"2023","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.xpro.2026.104717_bib146","article-title":"Trends in Obesity and Overweight in Oregon Children With Down Syndrome","volume":"6","author":"Pierce","year":"2019","journal-title":"Glob. Pediatr. Health"},{"key":"10.1016\/j.xpro.2026.104717_bib147","first-page":"566","article-title":"Long bone growth in Down\u2019s syndrome","volume":"112","author":"Rarick","year":"1966","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.xpro.2026.104717_bib148","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00198-013-2393-7","article-title":"Bone mass and density in preadolescent boys with and without Down syndrome","volume":"24","author":"Wu","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.xpro.2026.104717_bib149","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1352\/1934-9556-55.5.315","article-title":"Bone Mass Assessment in a Cohort of Adults With Down Syndrome: A Cross-Sectional Study","volume":"55","author":"Costa","year":"2017","journal-title":"Intellect. Dev. Disabil."},{"key":"10.1016\/j.xpro.2026.104717_bib150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jocd.2018.03.001","article-title":"Bone Mineral Density Distribution Curves in Spanish Adults With Down Syndrome","volume":"21","author":"Costa","year":"2018","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.xpro.2026.104717_bib151","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jir.12608","article-title":"Bone mineral density from early to middle adulthood in persons with Down syndrome","volume":"63","author":"Tang","year":"2019","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.xpro.2026.104717_bib152","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3233\/JAD-180141","article-title":"Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer\u2019s Disease","volume":"64","author":"Beam","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib153","article-title":"Tau pathology differs by sex in Alzheimer\u2019s disease in Down syndrome","volume":"21","author":"Chen","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.xpro.2026.104717_bib154","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.954999","article-title":"Exploring the role of sex differences in Alzheimer\u2019s disease pathogenesis in Down syndrome","volume":"16","author":"Andrews","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1522434","article-title":"Sex-related differences in genetically determined Alzheimer\u2019s disease","volume":"17","author":"Del Hoyo Soriano","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173404","article-title":"Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes","volume":"217","author":"Hawley","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.xpro.2026.104717_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106359","article-title":"Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model","volume":"190","author":"Hawley","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib158","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3390\/genes12111729","article-title":"Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts","volume":"12","author":"Thomas","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.xpro.2026.104717_bib159","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1093\/hmg\/ddv284","article-title":"Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a","volume":"24","author":"Blazek","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(02)00026-8","article-title":"Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome","volume":"134","author":"Martinez-Cu\u00e9","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.xpro.2026.104717_bib161","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbr.2005.04.016","article-title":"Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome","volume":"163","author":"Mart\u00ednez-Cu\u00e9","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.xpro.2026.104717_bib162","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1601-183X.2005.00175.x","article-title":"Anxiety and panic responses to a predator in male and female Ts65Dn mice, a model for Down syndrome","volume":"5","author":"Mart\u00ednez-Cu\u00e9","year":"2006","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.xpro.2026.104717_bib163","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/bpa.12073","article-title":"Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer\u2019s disease","volume":"24","author":"Kelley","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.xpro.2026.104717_bib164","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13590","article-title":"Temporal and brain region-specific elevations of soluble Amyloid-\u03b240-42 in the Ts65Dn mouse model of Down syndrome and Alzheimer\u2019s disease","volume":"21","author":"Tallino","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.xpro.2026.104717_bib165","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/alz.12463","article-title":"Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model","volume":"18","author":"Sawa","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.xpro.2026.104717_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106523","article-title":"Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model","volume":"196","author":"Lanzillotta","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib167","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.pbr.2019.10.003","article-title":"Modeling Down syndrome in cells: From stem cells to organoids","volume":"251","author":"Gough","year":"2020","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.xpro.2026.104717_bib168","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/cells11040628","article-title":"Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of GATA1 and STAG2 Mutations in Induced Pluripotent Stem Cells with Trisomy 21","volume":"11","author":"Barwe","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.xpro.2026.104717_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107012","article-title":"Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling","volume":"26","author":"Chi","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.xpro.2026.104717_bib170","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.stem.2022.06.007","article-title":"Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer\u2019s disease","volume":"29","author":"Jin","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xpro.2026.104717_bib171","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1007\/s12035-017-0818-6","article-title":"Down Syndrome iPSC-Derived Astrocytes Impair Neuronal Synaptogenesis and the mTOR Pathway In Vitro","volume":"55","author":"Araujo","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.xpro.2026.104717_bib172","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.neuron.2024.05.002","article-title":"Integrative multi-omic analysis reveals conserved cell-projection deficits in human Down syndrome brains","volume":"112","author":"Rastogi","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.xpro.2026.104717_bib173","article-title":"Asynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome","volume":"16","author":"Li","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib174","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/hmg\/ddae160","article-title":"Analysis of genotype effects and inter-individual variability in iPSC-derived trisomy 21 neural progenitor cells","volume":"34","author":"Lee","year":"2025","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib175","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.stemcr.2022.05.001","article-title":"Altered patterning of trisomy 21 interneuron progenitors","volume":"17","author":"Giffin-Rao","year":"2022","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xpro.2026.104717_bib176","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1038\/s41467-018-07630-y","article-title":"Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro","volume":"9","author":"Chiang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2026.104717_bib177","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.neuron.2025.03.036","article-title":"Chimeric brain models: Unlocking insights into human neural development, aging, diseases, and cell therapies","volume":"113","author":"Papetti","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.xpro.2026.104717_bib178","doi-asserted-by":"crossref","first-page":"eaau1810","DOI":"10.1126\/science.aau1810","article-title":"In vivo modeling of human neuron dynamics and Down syndrome","volume":"362","author":"Real","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xpro.2026.104717_bib179","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050403","article-title":"Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications","volume":"8","author":"Doss","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.xpro.2026.104717_bib180","doi-asserted-by":"crossref","DOI":"10.1063\/1.5038337","article-title":"Perspective: The promise of multi-cellular engineered living systems","volume":"2","author":"Kamm","year":"2018","journal-title":"APL Bioeng."},{"key":"10.1016\/j.xpro.2026.104717_bib181","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41556-023-01332-4","article-title":"Mechanical forces across compartments coordinate cell shape and fate transitions to generate tissue architecture","volume":"26","author":"Villeneuve","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xpro.2026.104717_bib182","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-neuro-111020-090812","article-title":"Challenges of Organoid Research","volume":"45","author":"Andrews","year":"2022","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib183","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41467-022-35619-1","article-title":"Large-scale perfused tissues via synthetic 3D soft microfluidics","volume":"14","author":"Grebenyuk","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2026.104717_bib184","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd1707","article-title":"Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases","volume":"7","author":"Trapecar","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xpro.2026.104717_bib185","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1038\/s41467-024-49781-1","article-title":"Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome","volume":"15","author":"Donovan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2026.104717_bib186","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/520000","article-title":"Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes","volume":"81","author":"A\u00eft Yahya-Graison","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib187","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.tibs.2015.03.011","article-title":"Gene dosage imbalances: action, reaction, and models","volume":"40","author":"Veitia","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.xpro.2026.104717_bib188","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1471-4159.2005.03624.x","article-title":"Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development","volume":"97","author":"Potier","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.xpro.2026.104717_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0020050","article-title":"Understanding the basis for Down syndrome phenotypes","volume":"2","author":"Roper","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib190","first-page":"875","article-title":"The natural history of Down syndrome conceptuses diagnosed prenatally that are not electively terminated","volume":"57","author":"Hook","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib191","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13059-015-0827-6","article-title":"Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models","volume":"16","author":"Mendioroz","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.xpro.2026.104717_bib192","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature13200","article-title":"Domains of genome-wide gene expression dysregulation in Down\u2019s syndrome","volume":"508","author":"Letourneau","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104717_bib193","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/18715273113126660186","article-title":"DYRK1A: a potential drug target for multiple Down syndrome neuropathologies","volume":"13","author":"Becker","year":"2014","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.xpro.2026.104717_bib194","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature06446","article-title":"Trisomy represses ApcMin -mediated tumours in mouse models of Down\u2019s syndrome","volume":"451","author":"Sussan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104717_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/717315","article-title":"The Use of Mouse Models for Understanding the Biology of Down Syndrome and Aging","volume":"2012","author":"Vacano","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"10.1016\/j.xpro.2026.104717_bib196","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.celrep.2018.05.011","article-title":"Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer\u2019s Disease","volume":"23","author":"Miranda","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xpro.2026.104717_bib197","doi-asserted-by":"crossref","first-page":"9415","DOI":"10.1073\/pnas.0803756105","article-title":"Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down\u2019s syndrome","volume":"105","author":"Voronov","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xpro.2026.104717_bib198","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/hmg\/dds142","article-title":"Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes","volume":"21","author":"Cossec","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib199","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down\u2019s syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.xpro.2026.104717_bib200","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1474-4422(25)00237-6","article-title":"Down syndrome and Alzheimer\u2019s disease: insights into biomarkers, clinical symptoms, and pathology","volume":"24","author":"Rafii","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xpro.2026.104717_bib201","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1128\/MCB.22.18.6636-6647.2002","article-title":"Dyrk1A Haploinsufficiency Affects Viability and Causes Developmental Delay and Abnormal Brain Morphology in Mice","volume":"22","author":"Fotaki","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xpro.2026.104717_bib202","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/hmg\/10.18.1915","article-title":"Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down\u2019s syndrome","volume":"10","author":"Altafaj","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib203","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn3314","article-title":"Down syndrome: the brain in trisomic mode","volume":"13","author":"Dierssen","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib204","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00401-008-0419-6","article-title":"The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome","volume":"116","author":"Wegiel","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xpro.2026.104717_bib205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mnfr.201300325","article-title":"Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans","volume":"58","author":"De la Torre","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.xpro.2026.104717_bib206","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.035634","article-title":"Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A","volume":"11","author":"Nguyen","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.xpro.2026.104717_bib207","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fnbeh.2015.00330","article-title":"Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome","volume":"9","author":"Catuara-Solarz","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib208","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1523\/ENEURO.0103-16.2016","article-title":"Combined Treatment With Environmental Enrichment and (-)-Epigallocatechin-3-Gallate Ameliorates Learning Deficits and Hippocampal Alterations in a Mouse Model of Down Syndrome","volume":"3","author":"Catuara-Solarz","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.xpro.2026.104717_bib209","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72625-z","article-title":"Re-establishment of the epigenetic state and rescue of kinome deregulation in Ts65Dn mice upon treatment with green tea extract and environmental enrichment","volume":"10","author":"De Toma","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xpro.2026.104717_bib210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nbd.2012.11.017","article-title":"Normalization of Dyrk1A expression by AAV2\/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome","volume":"52","author":"Altafaj","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib211","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","article-title":"Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down\u2019s syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"15","author":"de la Torre","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xpro.2026.104717_bib212","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1038\/s41380-024-02440-9","article-title":"The lncRNA Snhg11, a new candidate contributing to neurogenesis, plasticity, and memory deficits in Down syndrome","volume":"29","author":"Sierra","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.xpro.2026.104717_bib213","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1386944","article-title":"Lamivudine modulates the expression of neurological impairment-related genes and LINE-1 retrotransposons in brain tissues of a Down syndrome mouse model","volume":"16","author":"Borgognone","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib214","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1111\/jcmm.17411","article-title":"Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome","volume":"26","author":"Martinez de Lagran","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib215","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer\u2019s Disease: The Role of APP","volume":"56","author":"Doran","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib216","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410430316","article-title":"Molecular mapping of Alzheimer-type dementia in Down\u2019s syndrome","volume":"43","author":"Prasher","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xpro.2026.104717_bib217","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/brain\/awl203","article-title":"APP duplication is sufficient to cause early onset Alzheimer\u2019s dementia with cerebral amyloid angiopathy","volume":"129","author":"Sleegers","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.xpro.2026.104717_bib218","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xpro.2026.104717_bib219","doi-asserted-by":"crossref","first-page":"7ra17","DOI":"10.1126\/scitranslmed.3000258","article-title":"Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome","volume":"1","author":"Salehi","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib220","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1172\/JCI82409","article-title":"Amyloid precursor protein\u2013mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration","volume":"126","author":"Xu","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xpro.2026.104717_bib221","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/alz.12185","article-title":"Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model","volume":"17","author":"Chen","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.xpro.2026.104717_bib222","article-title":"Antisense oligonucleotides directed against App and Rab5 normalized endosomal Rab activity and reversed DS-AD-linked degenerative phenotypes in the Dp16 mouse model of Down syndrome","volume":"21","author":"Chen","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.xpro.2026.104717_bib223","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1279740","article-title":"Gamma-secretase modulators: a promising route for the treatment of Alzheimer\u2019s disease","volume":"16","author":"Nordvall","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib224","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1637671","article-title":"The manipulator behind \u201cScissors\u201d: \u03b3 -secretase and its modulators in Alzheimer\u2019s disease","volume":"17","author":"Ning","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib225","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202560","article-title":"Preclinical validation of a potent \u03b3-secretase modulator for Alzheimer\u2019s disease prevention","volume":"218","author":"Rynearson","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib226","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/jpet.117.240861","article-title":"Pharmacological and Toxicological Properties of the Potent Oral \u03b3-Secretase Modulator BPN-15606","volume":"362","author":"Wagner","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.xpro.2026.104717_bib227","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3233\/JAD-190442","article-title":"The GSM BPN-15606 as a Potential Candidate for Preventative Therapy in Alzheimer\u2019s Disease","volume":"73","author":"Prikhodko","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib228","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.26958","article-title":"\u03b3-Secretase Modulator BPN15606 Reduced A\u03b242 and A\u03b240 and Countered Alzheimer-Related Pathologies in a Mouse Model of Down Syndrome","volume":"96","author":"Chen","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xpro.2026.104717_bib229","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer\u2019s Disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.xpro.2026.104717_bib230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152471","article-title":"An Anti-\u03b2-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome","volume":"11","author":"Belichenko","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xpro.2026.104717_bib231","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58731","article-title":"Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome","volume":"9","author":"Zorrilla de San Martin","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.xpro.2026.104717_bib232","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002078","article-title":"DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in Down syndrome mouse models","volume":"21","author":"Liu","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.xpro.2026.104717_bib233","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2017.10.002","article-title":"GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome","volume":"114","author":"Zorrilla de San Martin","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.xpro.2026.104717_bib234","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fncel.2017.00054","article-title":"The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome","volume":"11","author":"Contestabile","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2013.11.010","article-title":"Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome","volume":"63","author":"Begenisic","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib236","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/bph.12169","article-title":"Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down\u2019s syndrome","volume":"169","author":"Colas","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.xpro.2026.104717_bib237","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsae300","article-title":"Short-term \u03b3-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model","volume":"48","author":"Pittaras","year":"2025","journal-title":"Sleep"},{"key":"10.1016\/j.xpro.2026.104717_bib238","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1523\/JNEUROSCI.1203-12.2013","article-title":"Reducing GABAA \u03b15 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome","volume":"33","author":"Mart\u00ednez-Cu\u00e9","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xpro.2026.104717_bib239","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/jn\/nxaa207","article-title":"Prenatal, but not Postnatal, Curcumin Administration Rescues Neuromorphological and Cognitive Alterations in Ts65Dn Down Syndrome Mice","volume":"150","author":"Rueda","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.xpro.2026.104717_bib240","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/jn\/nxaa074","article-title":"Prenatal Administration of Oleic Acid or Linolenic Acid Reduces Neuromorphological and Cognitive Alterations in Ts65dn Down Syndrome Mice","volume":"150","author":"Garc\u00eda-Cerro","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.xpro.2026.104717_bib241","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.brainresbull.2018.06.009","article-title":"Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome","volume":"140","author":"Giacomini","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.xpro.2026.104717_bib242","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2013.04.016","article-title":"Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome","volume":"58","author":"Velazquez","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib243","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/hipo.22832","article-title":"CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer\u2019s disease following maternal choline supplementation","volume":"28","author":"Alldred","year":"2018","journal-title":"Hippocampus"},{"key":"10.1016\/j.xpro.2026.104717_bib244","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/1567205012666150921100515","article-title":"Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome","volume":"13","author":"Kelley","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.xpro.2026.104717_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106332","article-title":"Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer\u2019s disease","volume":"188","author":"Gautier","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xpro.2026.104717_bib246","first-page":"103","article-title":"Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations","volume":"9","author":"Gardiner","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.xpro.2026.104717_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2024.110209","article-title":"A Systematic Online Living Evidence Summary of experimental Alzheimer\u2019s disease research","volume":"409","author":"Hair","year":"2024","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.xpro.2026.104717_bib248","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1042\/CS20220494","article-title":"Systematic online living evidence summaries: emerging tools to accelerate evidence synthesis","volume":"137","author":"Hair","year":"2023","journal-title":"Clin. Sci."},{"key":"10.1016\/j.xpro.2026.104717_bib249","doi-asserted-by":"crossref","first-page":"eadz4351","DOI":"10.1126\/science.adz4351","article-title":"Autonomous biomedical research with an artificial intelligence agent","author":"Huang","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.xpro.2026.104717_bib250","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/ajmg.a.34235","article-title":"Self-perceptions from people with Down syndrome","volume":"155A","author":"Skotko","year":"2011","journal-title":"Am. J. Med. Genet."}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166726003709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166726003709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:35:12Z","timestamp":1790120112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166726003709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":250,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666166726003709"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2026.104717","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Researcher\u2019s guide to rodent models of Down syndrome: Recent insights and translational perspectives","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2026.104717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104717"}}